ArticleProtein science : a publication of the Protein Society2025
Mini-αA-crystallin protects a client lens protein from catastrophic aggregation due to heat stress.
Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Key post-translational modifications of crystallin: from mechanism to target exploration for cataract diagnosis and treatment.Molecular biology reports · 2025Review
- Mini-αA-crystallin protects a client lens protein from catastrophic aggregation due to heat stress.Protein science : a publication of the Protein Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The clarity and refractivity of the eye lens are mediated by the highly soluble crystallin proteins. Post-translational modifications impact solubility and stability of the structural and refractive βγ-crystallins, eventually leading to cataract. Such damaged proteins are kept in solution by the holdase chaperone α-crystallins, maintaining lens transparency over decades despite the absence of protein turnover. It was previously found that a short peptide from human αA-crystallin (mini-αA-crystallin [MAAC]) retains some chaperone activity, with hydrophobic interactions hypothesized to mediate chaperone-client interactions; MAAC has been hypothesized to have β-strand structure in solution, although its conformational ensemble under these conditions has not been well-characterized. Here, we employ a combination of nuclear magnetic resonance (NMR), circular dichroism spectroscopy, dynamic light scattering, and molecular dynamics simulations to examine the behavior of MAAC in dilute solution and in combination with human γS-crystallin. Structural ensembles of two alanine variants of MAAC (I4A and L6A) show that the variants lack well-defined secondary structure, but have a preference for a bent conformation with some self-interaction. A partial alanine scan indicates that several hydrophobic residues are important for peptide solubility, also modifying the peptide's conformational ensemble. Tests of wild-type MAAC chaperone activity on thermally stressed γS-crystallin show little interaction between MAAC and the client protein below its unfolding temperature. However, MAAC does inhibit large-scale aggregation at the γS-crystallin unfolding temperature. NMR measurements indicate only weak, transient interaction with the client protein during the intermediate aggregation phase, suggesting a sharp phase transition in the MAAC-client system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.